Crossref
Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin
Diabetes Frontier Online · 16.12.2025 · 12 (e1) · 001-001
DOI: 10.15634/j0100_1201_006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Frontier Online, erschienen am 16.12.2025. Verfasst von Yutaka Mori.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mori, Y. (2025). Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin. Diabetes Frontier Online, 12(e1), 001-001. https://doi.org/10.15634/j0100_1201_006
Vancouver
Mori Y. Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin. Diabetes Frontier Online. 2025;12(e1):001-001. doi:10.15634/j0100_1201_006
BibTeX
@article{Mori2025,
author = {Mori, Yutaka},
title = {Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin},
journal = {Diabetes Frontier Online},
year = {2025},
volume = {12},
number = {e1},
pages = {001--001},
doi = {10.15634/j0100_1201_006}
}
EUVIMED